{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:06:46Z","timestamp":1788808006100,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"publisher","award":["2020-3735"],"award-info":[{"award-number":["2020-3735"]}],"id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12098-022-04205-0","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T03:12:41Z","timestamp":1654485161000},"page":"1003-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical Usefulness of Serum Lactate Dehydrogenase Levels in Mycoplasma pneumoniae Pneumonia in Children"],"prefix":"10.1007","volume":"89","author":[{"given":"Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insu","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"4205_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12879-020-4810-9","volume":"20","author":"E Lee","year":"2020","unstructured":"Lee E, Kim CH, Lee YJ, et al. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis. 2020;20:132.","journal-title":"BMC Infect Dis"},{"key":"4205_CR2","doi-asserted-by":"crossref","unstructured":"S\u00f8ndergaard MJ, Friis MB, Hansen DS, J\u00f8rgensen IM. Clinical manifestations in infants and children with Mycoplasma pneumoniae infection. PloS One. 2018;13:e0195288.","DOI":"10.1371\/journal.pone.0195288"},{"key":"4205_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3345\/kjp.2017.60.5.151","volume":"60","author":"E Lee","year":"2017","unstructured":"Lee E, Cho HJ, Hong SJ, Lee J, Sung H, Yu J. Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children. Korean J Pediatr. 2017;60:151\u20137.","journal-title":"Korean J Pediatr"},{"key":"4205_CR4","doi-asserted-by":"crossref","unstructured":"Lee E, Young Lee Y. Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance. Respir Med. 2020;175:106209.","DOI":"10.1016\/j.rmed.2020.106209"},{"key":"4205_CR5","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/ppul.25298","volume":"56","author":"YS Kim","year":"2021","unstructured":"Kim YS, Lee YY, Lee E. Cases of macrolide-resistant Mycoplasma pneumoniae pneumonia-associated pulmonary thromboembolism. Pediatr Pulmonol. 2021;56:1796\u20139.","journal-title":"Pediatr Pulmonol"},{"key":"4205_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","volume":"16","author":"H Lee","year":"2018","unstructured":"Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018;16:23\u201334.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4205_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fmicb.2016.00023","volume":"7","author":"M Narita","year":"2016","unstructured":"Narita M. Classification of extrapulmonary manifestations due to mycoplasma pneumoniae infection on the basis of possible pathogenesis. Front Microbiol. 2016;7:23.","journal-title":"Front Microbiol"},{"key":"4205_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/BOR.0000000000000494","volume":"30","author":"D Poddighe","year":"2018","unstructured":"Poddighe D. Extra-pulmonary diseases related to Mycoplasma pneumoniae in children: recent insights into the pathogenesis. Curr Opin Rheumatol. 2018;30:380\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"4205_CR9","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z. The clinical characteristics and predictors of refractory mycoplasma pneumoniae pneumonia in children. Plos One. 2016;11:e0156465.","DOI":"10.1371\/journal.pone.0156465"},{"key":"4205_CR10","doi-asserted-by":"crossref","unstructured":"Gong H, Sun B, Chen Y, Chen H. The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: A meta-analysis. Medicine (Baltimore). 2021;100:e24894.","DOI":"10.1097\/MD.0000000000024894"},{"key":"4205_CR11","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/ppul.24684","volume":"55","author":"S Cheng","year":"2020","unstructured":"Cheng S, Lin J, Zheng X, et al. Development and validation of a simple-to-use nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2020;55:968\u201374.","journal-title":"Pediatr Pulmonol"},{"key":"4205_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12931-020-01427-8","volume":"21","author":"MY Wu","year":"2020","unstructured":"Wu MY, Yao L, Wang Y, et al. Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia. Respir Res. 2020;21:171.","journal-title":"Respir Res"},{"key":"4205_CR13","doi-asserted-by":"publisher","first-page":"39929","DOI":"10.1038\/srep39929","volume":"6","author":"Y Yan","year":"2016","unstructured":"Yan Y, Wei Y, Jiang W, Hao C. The clinical characteristics of corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in children. Sci Rep. 2016;6:39929.","journal-title":"Sci Rep"},{"key":"4205_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jiac.2014.01.001","volume":"20","author":"N Inamura","year":"2014","unstructured":"Inamura N, Miyashita N, Hasegawa S, et al. Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level. J Infect Chemother. 2014;20:270\u20133.","journal-title":"J Infect Chemother"},{"key":"4205_CR15","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4187\/respcare.03920","volume":"60","author":"A Lu","year":"2015","unstructured":"Lu A, Wang C, Zhang X, Wang L, Qian L. Lactate dehydrogenase as a biomarker for prediction of refractory mycoplasma pneumoniae pneumonia in children. Respir Care. 2015;60:1469\u201375.","journal-title":"Respir Care"},{"key":"4205_CR16","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/jcm10061154","volume":"10","author":"E Lee","year":"2021","unstructured":"Lee E, Lee YY. Predictive factors of the responses to treatment of mycoplasma pneumoniae pneumonia. J Clin Med. 2021;10:1154.","journal-title":"J Clin Med"},{"key":"4205_CR17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","volume":"7","author":"S Pereyre","year":"2016","unstructured":"Pereyre S, Goret J, B\u00e9b\u00e9ar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974.","journal-title":"Front Microbiol"},{"key":"4205_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/INF.0000000000002529","volume":"39","author":"LL Sun","year":"2020","unstructured":"Sun LL, Ye C, Zhou YL, Zuo SR, Deng ZZ, Wang CJ. Meta-analysis of the clinical efficacy and safety of high- and low-dose methylprednisolone in the treatment of children with severe mycoplasma pneumoniae pneumonia. Pediatr Infect Dis J. 2020;39:177\u201383.","journal-title":"Pediatr Infect Dis J"},{"key":"4205_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12890-019-0990-8","volume":"19","author":"HS Kim","year":"2019","unstructured":"Kim HS, Sol IS, Li D, et al. Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials. BMC Pulm Med. 2019;19:251.","journal-title":"BMC Pulm Med"},{"key":"4205_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/jcm8050726","volume":"8","author":"EA Yang","year":"2019","unstructured":"Yang EA, Kang HM, Rhim JW, Kang JH, Lee KY. Early corticosteroid therapy for mycoplasma pneumoniae pneumonia irrespective of used antibiotics in children. J Clin Med. 2019;8:726.","journal-title":"J Clin Med"},{"key":"4205_CR21","doi-asserted-by":"crossref","unstructured":"Qiu JL, Huang L, Shao MY, et al. Efficacy and safety of azithromycin combined with glucocorticoid on refractory Mycoplasma pneumoniae pneumonia in children: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2020;99:e20121.","DOI":"10.1097\/MD.0000000000020121"},{"key":"4205_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jmii.2020.10.002","volume":"54","author":"TA Tsai","year":"2021","unstructured":"Tsai TA, Tsai CK, Kuo KC, Yu HR. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect. 2021;54:557\u201365.","journal-title":"J Microbiol Immunol Infect"},{"key":"4205_CR23","doi-asserted-by":"crossref","unstructured":"Ishiguro N, Koseki N, Kaiho M, et al. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. PloS one. 2017;12:e0173635.","DOI":"10.1371\/journal.pone.0173635"},{"key":"4205_CR24","doi-asserted-by":"crossref","unstructured":"Chen IC, Hsu JS, Chen YW, et al. Post-infectious bronchiolitis obliterans: HRCT, DECT, Pulmonary Scintigraphy images, and clinical follow-up in eight children. Front Pediatr. 2020;8:622065.","DOI":"10.3389\/fped.2020.622065"},{"key":"4205_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3345\/kjp.2015.58.6.211","volume":"58","author":"KW Kim","year":"2015","unstructured":"Kim KW, Sung JJ, Tchah H, et al. Hepatitis associated with Mycoplasma pneumoniae infection in Korean children: a prospective study. Korean J Pediatr. 2015;58:211\u20137.","journal-title":"Korean J Pediatr"},{"key":"4205_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10156-011-0265-7","volume":"17","author":"T Oishi","year":"2011","unstructured":"Oishi T, Narita M, Matsui K, et al. Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia. J Infect Chemother. 2011;17:803\u20136.","journal-title":"J Infect Chemother"},{"key":"4205_CR27","doi-asserted-by":"crossref","unstructured":"Huang L, Huang X, Jiang W, Zhang R, Yan Y, Huang L. Independent predictors for longer radiographic resolution in patients with refractory mycoplasma pneumoniae pneumonia: a prospective cohort study. BMJ Open. 2018;8:e023719.","DOI":"10.1136\/bmjopen-2018-023719"},{"key":"4205_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jfma.2020.08.018","volume":"120","author":"KL Lee","year":"2021","unstructured":"Lee KL, Lee CM, Yang TL, et al. Severe mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010\u20132019. J Formos Med Assoc. 2021;120:281\u201391.","journal-title":"J Formos Med Assoc"},{"key":"4205_CR29","unstructured":"Safari S, Baratloo A, Elfil M, Negida A. Evidence based emergency medicine; part 5 receiver operating curve and area under the curve. emerg (Tehran). 2016;4:111\u20133."}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-022-04205-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-022-04205-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-022-04205-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T03:33:06Z","timestamp":1663385586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-022-04205-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["4205"],"URL":"https:\/\/doi.org\/10.1007\/s12098-022-04205-0","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"assertion":[{"value":"8 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}